Cytomx Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Cytomx Therapeutics by Goldman Sachs Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $133k | 109k | 1.22 |
2024-03-31 | $641k | 294k | 2.18 |
2023-06-30 | $18k | 10k | 1.72 |
2023-03-31 | $20k | 13k | 1.51 |
2022-12-31 | $166k | 104k | 1.60 |
2022-06-30 | $343k | 188k | 1.83 |
2022-03-31 | $2.0M | 759k | 2.67 |
2021-12-31 | $2.8M | 637k | 4.33 |
2021-09-30 | $5.6M | 1.1M | 5.09 |
2021-03-31 | $1.6M | 209k | 7.73 |
2020-12-31 | $1.5M | 227k | 6.55 |
2020-09-30 | $1.9M | 280k | 6.65 |
2020-06-30 | $2.3M | 278k | 8.33 |
2019-12-31 | $3.3M | 401k | 8.31 |
2019-09-30 | $2.9M | 389k | 7.38 |
2019-06-30 | $4.6M | 406k | 11.22 |
2019-03-31 | $2.1M | 197k | 10.75 |
2018-12-31 | $7.5M | 498k | 15.10 |
2018-09-30 | $8.4M | 456k | 18.50 |
2018-06-30 | $12M | 521k | 22.86 |
2018-03-31 | $12M | 419k | 28.44 |
2017-12-31 | $9.7M | 458k | 21.11 |
2017-09-30 | $5.9M | 325k | 18.18 |
2017-06-30 | $2.0M | 128k | 15.49 |
2017-03-31 | $190k | 11k | 17.30 |
2015-12-31 | $319k | 15k | 20.88 |